Diode Laser Transscleral Cyclophotocoagulation in Combination with Trabeculectomy for Surgical Therapy of Canine Refractory Glaucoma
نویسندگان
چکیده
In dogs, glaucoma is one of difficult diseases to be controlled. In this study, we evaluated advantage of diode laser transscleral cyclophotocoagulation (TSCP) in combination with trabeculectomy for a new treatment of glaucoma in canine subjects. Under general anesthesia, diode laser was delivered at a site 2–3 mm posterior to the limbus. After TSCP, trabeculectomy was performed to avoid postoperative ocular hypertension. The intraocular pressure (IOP) was monitored regularly for more than 3 months after surgery. Effectiveness of the combination therapy was compared with independent treatment of TSCP or trabeculectomy. In most dogs that were received the combination therapy, the IOP was normalized by a single treatment. On the other hand, in dogs treated with TSCP alone or treated with trabeculectomy alone, the IOP was not acceptably controlled. Combined TSCP with trabeculectomy may be effective for normalizing the IOP in refractory glaucoma in dogs without remarkable side effects.
منابع مشابه
Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.
BACKGROUND Inflammatory glaucoma is still a diagnostic and therapeutic dilemma and surgical intervention is always associated with a high risk of failure or reactivation of the inflammatory disease. In this study we prospectively examined the value of transscleral diode laser cyclophotocoagulation (TDLC) for the treatment of refractory inflammatory glaucoma. METHODS 22 eyes of 20 consecutive ...
متن کاملLong-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma
Objective: To study success rate and long term efficacy and complications of the transscleral diode laser Cyclophotocoagulation in refractory glaucoma. Patients and Methods: In a noncomparative interventional case series, eyes of 9 patients with glaucoma resistant to conventional medical and surgical therapies were treated with transscleral diode laser Cyclophotocoagulation from 2004 to 2007. C...
متن کاملWhat's new in laser treatment for glaucoma?
PURPOSE OF REVIEW This review highlights recently published studies on prevailing and newer laser therapies in glaucoma and critically evaluates their roles in the treatment algorithm. RECENT FINDINGS Recently published studies suggest a role for selective laser trabeculoplasty (SLT) as initial therapy for open-angle glaucoma and ocular hypertension and have demonstrated efficacy in other gla...
متن کاملTransscleral red laser cyclophotocoagulation for the treatment of therapy-resistant inflammatory glaucoma.
PURPOSE To evaluate in a retrospective study the long-term usefulness of red 647 nm krypton and 670 nm diode laser for transscleral contact cyclophotocoagulation (CPC) in the treatment of therapy-resistant inflammatory glaucoma. METHODS The authors treated 48 eyes of 38 consecutive patients (mean age 36.8 years, range 6-81 years) with therapy-resistant inflammatory glaucoma secondary to chron...
متن کاملManagement of Neovascular Glaucoma
Management of NVG remains a therapeutic challenge. The diagnosis of NVG should be made as early as possible if the patient is to be provided the best chance to maintain vision. To achieve this goal, a high index of suspicion, a full ocular examination including undilated gonioscopy, and pupil examination are essential. There are two key aspects to the management of NVG: treatment of the underly...
متن کامل